Investigating neutron activated contrast agent imaging for tumor localization in proton therapy: a feasibility study for proton neutron gamma-x detection (PNGXD)
Authors:
- Kurt W Van DelinderKDKurt W Van Delinder
- Daniel CrawfordDCDaniel Crawford
- Tiezhi ZhangTZTiezhi Zhang
- Rao KhanRKRao Khan
- James L GräfeJGJames L Gräfe
- 24 January 2020
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (3) , 035005
Abstract
Proton neutron gamma-x detection (PNGXD) is a novel imaging concept being investigated for tumor localization during proton therapy that uses secondary neutron interactions with a gadolinium contrast agent (GDCA) to produce characteristic photons within the 40–200 keV energy region. The purpose of this study is to experimentally investigate the feasibility of implementing this procedure by performing experimental measurements on a passive double scattering proton treatment unit. Five experimental measurements were performed with varying concentrations and irradiation conditions. Photon spectra were measured with a 25 mm 2 , 1 mm thick uncollimated X-123 CdTe spectrometer. For a 10.4 Gy administration on a 100 ml volume phantom with 10 mg g −1 Gd solution placed in a water phantom, 1129 ± 184 K-shell Gd counts were detected. For an administered dose of 21 Gy and the same Gd solution measured in air, resulted in 3296 ± 256 counts. A total of 1094 ± 171, 421 ± 150 and 23 ± 141 K-shell Gd counts were measured for Gd concentrations of 10 mg g −1 , 1 mg g −1 and 0 mg g −1 for 7 Gy dose in air. The signal to noise ratio for these five measurements were: 7, 15, 6, 3, and 0.2, respectively. The spectrum contained 43 keV K α and 49 keV K β peaks, however a small amount of 79.5 and 181.9 keV prompt gamma rays were detected from gadolinium neutron capture. This discrepancy is due to a drop in the intrinsic detection efficiency of the CdTe spectrometer over this energy range. The measurements were compared with Monte-Carlo simulation to determine the contributions of Gd neutron capture from internal and external neutrons on a passive scattering proton therapy unit and to investigate the discrepancy in detected characteristic x-rays versus prompt gamma rays.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN/4386-2017)
This publication has 35 references indexed in Scilit:
- Vision 20/20: Single photon counting x‐ray detectors in medical imagingMedical Physics, 2013
- Range uncertainties in proton therapy and the role of Monte Carlo simulationsPhysics in Medicine & Biology, 2012
- Creating a spread-out Bragg peak in proton beamsPhysics in Medicine & Biology, 2011
- Theoretical variance analysis of single- and dual-energy computed tomography methods for calculating proton stopping power ratios of biological tissuesPhysics in Medicine & Biology, 2010
- Measurement and calculation of characteristic prompt gamma ray spectra emitted during proton irradiationPhysics in Medicine & Biology, 2009
- Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scansPhysics in Medicine & Biology, 2009
- Patient Study of In Vivo Verification of Beam Delivery and Range, Using Positron Emission Tomography and Computed Tomography Imaging After Proton TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Monte Carlo study of neutron dose equivalent during passive scattering proton therapyPhysics in Medicine & Biology, 2007
- The prediction of output factors for spread-out proton Bragg peak fields in clinical practicePhysics in Medicine & Biology, 2005
- Calculations of neutron dose equivalent exposures from range-modulated proton therapy beamsPhysics in Medicine & Biology, 2005